Story thread · 2 reports / 2 sources
The FDA was all in on AI. Will that change?
medtechdive.com · 13d
High-level turnover has introduced uncertainty about how quickly the FDA’s agency-wide AI strategy will move forward.
First report: The FDA was all in on AI. Will that change? — biopharmadive.com, 14d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.